Home › Funds › Aristotle Atlantic Partners, LLC › TECH

Aristotle Atlantic Partners, LLC position in TECH

BIO-TECHNE CORP · Health Care

Aristotle Atlantic Partners, LLC reported holding 659,537 shares of TECH (BIO-TECHNE CORP) in its Q2 2026 13F filing — a position valued at US$46.6M, representing 1.93% of its reported portfolio and ranking #16 among its reported holdings. Aristotle Atlantic Partners, LLC has disclosed TECH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)659.54K sh
Reported value held$46.60M
Portfolio Weight1.93%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Aristotle Atlantic Partners, LLC's TECH position evolved

Aristotle Atlantic Partners, LLC first disclosed a stake in TECH in Q3 2023 at 653,635 shares (US$44.5M). The position peaked in Q3 2024 at 785,504 shares, worth US$62.8M. Across 12 filings, Aristotle Atlantic Partners, LLC increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 659,537 shares valued at US$46.6M — an increase of 46,711 shares quarter over quarter.. Notable position changes include a 28% increase in Q1 2025 (shares fell 12% over the following quarter), a 38% trim in Q4 2025 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 653.63K $44.49M New
Q4 2023 759.41K $58.60M Add
Q1 2024 735.76K $51.79M Reduce
Q2 2024 721.67K $51.71M Reduce
Q3 2024 785.50K $62.79M Add
Q4 2024 754.36K $54.34M Reduce
Q1 2025 966.37K $56.66M Add
Q2 2025 1.05M $54.14M Add
Q3 2025 1.03M $57.15M Reduce
Q4 2025 636.82K $37.45M Reduce
Q1 2026 612.83K $32.03M Reduce
Q2 2026 659.54K $46.60M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TECH and 13F data

TECH (BIO-TECHNE CORP) is a Health Care company. 29 other funds we track also report a position in TECH — the largest reported positions include HBK INVESTMENTS L P (US$482.2M), Ruane Cunniff & Goldfarb (Sequoia) (US$236.6M), SNYDER CAPITAL MANAGEMENT L P (US$223.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TECH

All TECH fund holders →

FAQ

How long has Aristotle Atlantic Partners, LLC held TECH?

Aristotle Atlantic Partners, LLC has disclosed TECH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Aristotle Atlantic Partners, LLC's current position in TECH?

As of Q2 2026, Aristotle Atlantic Partners, LLC holds 659.54K shares of TECH (BIO-TECHNE CORP), valued at $46.60M, representing 1.93% of its reported portfolio and ranking #16.

Has Aristotle Atlantic Partners, LLC been buying or selling TECH?

In the latest 13F filing (Q2 2026), Aristotle Atlantic Partners, LLC increased its position in TECH. The position peaked in Q3 2024 at 785.50K shares.

Which other funds hold TECH?

Other major institutional holders of TECH include HBK INVESTMENTS L P, Ruane Cunniff & Goldfarb (Sequoia), SNYDER CAPITAL MANAGEMENT L P, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.